Drug firm Elder Pharmaceuticals has planned to enter the Japanese pharma market during the current fiscal, as it had received accreditation from the Japanese Ministry of Health for its Patalganga facility. It has filed for new patents in these markets. So hopefully it should get these during the current financial year, which would open up another $500 million market .The Japanese pharmaceutical market is valued at about $70 billion. It has a plan to actually try to get about 1-2% of the market share. The company's plant at Patalganga manufactures active pharmaceutical ingredients (APIs).It has also developed two products going off-patent in the Japanese market in 2014. One of the products is from the central nervous system (CNS) category and the second is from the gastrointestinal (GI) segment. Elder has already filed a PCT patent (an international patent application) for one of the advanced intermediates for the Japanese market and is in talks with Japanese generic companies for supply contracts. Spending on generic drugs in Japan, the second-largest pharma market in the world, is on the rise and the government is targeting to increase the share of these low-cost alternatives to 30% of overall healthcare spending by 2013.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1777.20 |
| Dr. Reddys Lab | 1206.90 |
| Cipla | 1485.00 |
| Lupin | 2055.65 |
| Zydus Lifesciences | 945.10 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
